TREATMENT OF NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) WITH ALL TRANSRETINOIC ACID (ATRA) FOLLOWED BY INTENSIVE CHEMOTHERAPY (CT) - UPDATED RESULTS OF THE EUROPEAN GROUP

被引：0
|
作者：
FENAUX, P
CHASTANG, C
CASTAIGNE, S
ARCHIMBAUD, E
SANZ, M
LINK, H
GUERCI, A
FEGUEUX, N
ZITTOUN, R
STOPPA, AM
TRAYADE, P
LAMY, T
MALOISEL, F
SADOUN, A
SANMIGUEL, J
VEIL, A
RAYON, C
CONDE, E
FEY, M
BORDESSOULE, D
GANSER, A
BOWEN, D
DREYFUS, F
HUGUET, F
TILLY, H
GUY, H
AUZANNEAU, G
CHOMIENNE, C
DEGOS, L
机构：
来源：
BLOOD | 1994年 / 84卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A379 / A379
页数：1
相关论文
共 50 条
  • [21] The role of all-trans-retinoic acid (ATRA) treatment in newly-diagnosed acute promyelocytic leukemia patients aged >60 years
    Latagliata, R
    Avvisati, G
    Lo Coco, F
    Petti, MC
    Diverio, D
    Spadea, A
    Fazi, P
    Torromeo, C
    Breccia, M
    Malagnino, F
    Mandelli, F
    ANNALS OF ONCOLOGY, 1997, 8 (12) : 1273 - 1275
  • [22] Outcome of acute promyelocytic leukemia (APL) with very high WBC counts treated with ATRA and chemotherapy (CT): The European group experience
    Kelaidi, C.
    Chevret, S.
    De Botton, S.
    Raffoux, E.
    Guerci, A.
    Thomas, X.
    Gardin, C.
    Pigneux, A.
    Stoppa, A.
    Lamy, T.
    Rigal-Huguet, F.
    Vekboff, A.
    Meyer-Monard, S.
    Stoppa, A.
    Lamy, T.
    Rigal-Huguet, F.
    Vekboff, A.
    Meyer-Monard, S.
    Ghelo, R.
    Pabst, T.
    Chevalier, P.
    Maloisel, F.
    Deconinck, E.
    Ferrant, A.
    Bron, D.
    Fegueux, N.
    De la Serna, J.
    Martin, G.
    Cahn, J.
    Ifrah, N.
    Cassinat, B.
    Dombret, H.
    Sanz, M. A.
    Fehaux, Pierre
    Ades, L.
    BLOOD, 2007, 110 (11) : 546A - 546A
  • [23] The role of all-trans retinoic acid (ATRA) treatment in newly diagnosed acute promyelocytic leukemia (APL) patients aged > 60 yrs.
    Latagliata, R
    Petti, MC
    Diverio, D
    Fazi, P
    Mecarocci, S
    Montefusco, E
    Redi, R
    Spadea, A
    Torromeo, MC
    Avvisati, G
    BLOOD, 1996, 88 (10) : 3425 - 3425
  • [24] Treatment of newly-diagnosed acute promyelocytic leukemia (APL) without cytosine arabinoside (ARA-C)
    Estey, E
    Andreeff, M
    OBrien, S
    Kantarjian, H
    BLOOD, 1995, 86 (10) : 1049 - 1049
  • [25] ANALYSIS OF TREATMENT OUTCOME OF ALL PATIENTS WITH NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL): NO DIFFERENCE IN SURVIVAL BEFORE AND AFTER ATRA ERA
    Koristek, Z. K.
    Schwarz, J.
    Stary, J.
    Zak, P.
    Kozak, T.
    Mayer, J.
    Cetkovsky, P.
    Markova, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 481 - 482
  • [26] Outcome of acute promyelocytic leukemia (APL) treated with all trans retinoic acid (ATRA) and chemotherapy (CT) in elderly patients (>60 years):: The European Group experience.
    Ades, L
    Chevret, S
    de Botton, S
    Thomas, X
    Dombret, H
    Sanz, M
    Guerci, A
    San Miguel, J
    De La Serna, J
    Garo, C
    Stoppa, AM
    Reman, O
    Stamatoullas, A
    Gardin, C
    Fey, M
    Cahn, JY
    Sotto, JJ
    Bourhis, JH
    Parry, A
    Chomienne, C
    Degos, L
    Fenaux, P
    BLOOD, 2003, 102 (11) : 619A - 619A
  • [27] Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) results of a randomized study.
    de Botton, S
    Coitteux, V
    Chevret, S
    Dombret, H
    Sanz, M
    San Miguel, J
    Caillot, D
    Vekhof, A
    Gardembas, M
    Stamatoullas, A
    Condé, E
    Guerci, A
    Gardin, C
    Fey, M
    Jacky, E
    Makhoul, DC
    Reman, O
    de la Serna, J
    Lefrere, F
    Chomienne, C
    Degos, L
    Fenaux, P
    BLOOD, 2001, 98 (11) : 766A - 766A
  • [28] Long-Term Outcome of All-Trans-Retinoic-Acid(ATRA) plus Intensive Chemotherapy in Acute Promyelocytic Leukemia(APL)
    Kyo, Taiichi
    Okatani, Takeshi
    Kyo, Kouhei
    Itagaki, Mitsuhiro
    Imanaka, Ryouta
    Iwato, Koji
    Asaoku, Hidkeki
    Katayama, Yuuta
    BLOOD, 2011, 118 (21) : 1539 - 1539
  • [29] All-trans retinoic acid therapy for newly diagnosed acute promyelocytic leukemia: Comparison with intensive chemotherapy
    Asou, N
    Adachi, K
    Tamura, J
    Kanamaru, A
    Kageyama, S
    Hiraoka, A
    Omoto, E
    Sakamaki, H
    Tsubaki, K
    Saito, K
    Ohno, R
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (Suppl 1) : S30 - S35
  • [30] All-trans retinoic acid therapy for newly diagnosed acute promyelocytic leukemia: comparison with intensive chemotherapy
    N. Asou
    Koichi Adachi
    Jun-ichi Tamura
    Akihisa Kanamaru
    Shin-ichi Kageyama
    Akira Hiraoka
    Eijiro Omoto
    Hisashi Sakamaki
    Kazuo Tsubaki
    Kenji Saito
    Ryuzo Ohno
    Cancer Chemotherapy and Pharmacology, 1997, 40 : S30 - S35
12345